Lilly(Eli) & Company
NYSE: LLY
$921.49
+$6.45 (+0.7%)
Closing Price on September 20, 2024
LLY Articles
March 17, 2016: Here are four stocks trading with heavy volume among 60 equities making new 52-week lows in Thursday’s session. Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped...
Published:
Last Updated:
March 15, 2016: Here are four stocks trading with heavy volume among 33 equities making new 52-week lows in Tuesday’s session. Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped by more...
Published:
Last Updated:
For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made a couple additions and updated its price target information.
Published:
Last Updated:
With investors looking for safety and dividends for total return, the big pharmaceutical stocks are just the ticket, and these four are outstanding.
Published:
Last Updated:
In a new research report, Jefferies shuffles some of the pharmaceutical stocks in its coverage universe and a beaten-down dividend leader is now the top pick globally.
Published:
Last Updated:
If you ever want to look for value in a sector in the stock market, then when you see Congress calling in some of the top companies to scold them for political purposes, you may want to start buying.
Published:
Last Updated:
24/7 Wall St. screened the Merrill Lynch research universe database and found four outstanding dividend stocks that are rated Buy and also offer tremendous value now.
Published:
Last Updated:
24/7 Wall St. screened the list of the top Merrill Lynch picks for the dividend yielding stocks that are on sale and found four outstanding ones to buy now.
Published:
Last Updated:
One good plan for stockholders who are seeing gains evaporate is to rotate to a more defensive sector. Large cap pharmaceutical stocks totally fit the bill.
Published:
Last Updated:
The top analyst calls for Wednesday, January 6, 2016, include Bluebird Bio, Check Point Software, Comcast, Eli Lilly, Hyatt Hotels, Lockheed Martin and Rite Aid.
Published:
Last Updated:
These companies all provide drugs and medical devices that help hundreds of thousands of people daily lead a better life. They make good sense for conservative portfolios looking for income and...
Published:
Last Updated:
With oil plunging, and the market reeling from what should prove to be extremely good news for consumers, many investors are in a quandary over which path to take for 2016.
Published:
Last Updated:
Wednesday's top analyst upgrades, downgrades and initiations include Agilent, CSC, Intel, Jabil Circuit, Kinder Morgan, Nasdaq, Square and Yahoo.
Published:
Last Updated:
Brokerage firm Jefferies has released its top pharmaceutical picks for the coming year and what to expect.
Published:
Last Updated:
Monday's top analyst upgrades, downgrades and initiations include Abbott Labs, Bluebird Bio, Chipotle, Eli Lilly, Ferrari and Wells Fargo.
Published:
Last Updated: